Company Shanghai Yizhong Pharmaceutical Co., Ltd.

688091

CNE1000050F4

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Specialty & Advanced Pharmaceuticals

SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
24.29 ^CNY	+3.19%		-3.46%	-50.66%

04-30	Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	RE
04-29	Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Shanghai Yizhong Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development and industrialization of new and improved anti-tumor drugs. The Company's main products include paclitaxel micelles, docetaxel micelles and cabazitaxel micelles. Paclitaxel micelles are products under development that have been submitted for registration and marketing applications, and their indications are non-small cell lung cancer. Docetaxel micelles and cabazitaxel micelles are products under development in the pre-clinical research stage.

Number of employees: 304

CNY in Million	2022	Weight	2023	Weight	Delta
Chemical and Pharmaceutical 100.0 %	236	100.0 %	360	100.0 %	+52.68%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	236	100.0 %	360	100.0 %	+52.68%

Managers	Title	Age	Since
Duan Li FOU	Founder	84	09/09/09
Jin Song Zhou CEO	Chief Executive Officer	56	09/09/09
Ruo Yun Pan CHM	Chairman	43	31/07/17
Xin Ran Meng BRD	Director/Board Member	31	30/04/19
Jing Sun BRD	Director/Board Member	47	30/09/09
Zhou Fang SEC	Corporate Secretary	36	31/05/18

Members of the board	Title	Age	Since
Jin Song Zhou CEO	Chief Executive Officer	56	09/09/09
Duan Li FOU	Founder	84	09/09/09
Jing Sun BRD	Director/Board Member	47	30/09/09
Xue Hang Du BRD	Director/Board Member	56	29/02/16
Yan Ren Xiong BRD	Director/Board Member	52	08/03/20
Gai Rong Hu BRD	Director/Board Member	47	08/03/20
Chun Meng Sun BRD	Director/Board Member	39	08/03/20
Ruo Yun Pan CHM	Chairman	43	31/07/17
Xin Ran Meng BRD	Director/Board Member	31	30/04/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	205,759,840	81,805,132 ( 39.76 %)	0	39.76 %

Name	Equities	%	Valuation
SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD 16.35 %	24,703,546	16.35 %	92 M ¥
Feng Li 4.635 %	7,001,280	4.635 %	26 M ¥
Duan Li 4.611 %	6,964,329	4.611 %	26 M ¥
Shanghai Xianyu Investment LP 4.599 %	6,946,940	4.599 %	26 M ¥
Xun Li 4.488 %	6,779,072	4.488 %	25 M ¥
Shanghai Yixian Health Management Consulting LP 2.690 %	4,063,886	2.690 %	15 M ¥
Yuan Zhang 2.347 %	3,544,801	2.347 %	13 M ¥
Mei Hua Zeng 1.927 %	2,911,194	1.927 %	11 M ¥
Hua Dong Luo 1.267 %	1,913,022	1.267 %	7 M ¥
Jing Sun 1.266 %	1,911,954	1.266 %	7 M ¥

Name	Equities	%	Valuation
Jin Song Zhou 73.34 %	40,127,058	73.34 %	149 M ¥
Shanghai Shanyuan Enterprise Management LP 17.77 %	9,724,000	17.77 %	36 M ¥
Shanghai Yixing Enterprise Management LP 8.886 %	4,862,000	8.886 %	18 M ¥

Shanghai Yizhong Pharmaceutical Co., Ltd.

79 Renqi Road Fengxian District

201403, Shanghai

http://www.yizhongpharma.com

address Shanghai Yizhong Pharmaceutical Co., Ltd.(688091)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	-50.66%	688M
MERCK KGAA	+8.43%	72.21B
KYOWA KIRIN CO. LTD.	+14.98%	9.14B
SK BIOPHARMACEUTICALS CO., LTD.	-23.31%	4.33B
YUHAN CORPORATION	+15.70%	4.28B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+32.83%	4.15B
INDIVIOR PLC	+9.54%	2.19B
BETTA PHARMACEUTICALS CO., LTD.	-33.37%	1.98B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+9.30%	1.98B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-46.20%	1.68B

Specialty & Advanced Pharmaceuticals